ADVFN - Advanced Financial Network.
HOME» NYSE » N » NVO Stock Price » NVO Stock News

Novo Nordisk a S Share News

 Novo-nordisk a/s (denmark) Stock Price
NVO Stock Price
 Novo-nordisk a/s (denmark) Stock Chart
NVO Stock Chart
 Novo-nordisk a/s (denmark) Stock News
NVO Stock News
 Novo-nordisk a/s (denmark) Company Information
NVO Company Information
 Novo-nordisk a/s (denmark) Stock Trades
NVO Stock Trades

Novo Nordisk May Perform Stock Split - Chief Financial Officer

COPENHAGEN -(Dow Jones)- Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.KO) may perform a stock split in the next couple of years, the company's chief financial officer Jesper Brandgaard said Thursday. "We have done several stock splits over the years, when the price has risen to levels that we found too high. With a price of more than $100, it is something we will consider again," Brandgaard said, speaking after the company released its fourth-quarter results. Novo Nordisk, the world's largest maker of insulin, earlier Thursday reported that its net profit rose 19% on the year in the fourth quarter, to 4.69 billion Danish kroner ($829 million). The result was better than expected, helped by strong growth in sales of its GLP-1 diabetes drug Victoza and ultra-long acting insulin Levemir. -By Flemming Emil Hansen and Niclas Rolander, Dow Jones Newswires; +46-8-5451-3102;

Stock News for Novo Nordisk a S (NVO)
07/02/201506:08:47Report of Foreign Issuer (6-k)
07/02/201506:08:47Report of Foreign Issuer (6-k)
07/01/201511:58:46Novo Nordisk to Stop Selling Key Insulin Drug in Germany
06/22/201509:00:07Report of Foreign Issuer (6-k)
06/17/201511:00:00Tour de Beauce : L'équipe Novo Nordisk s'illustre à nouveau e...
06/17/201511:00:00The Results are in… Team Novo Nordisk caps off another successful C...
06/17/201509:04:025 Healthcare Stocks for Dividend Lovers
06/15/201509:28:15Report of Foreign Issuer (6-k)
06/08/201510:42:42Report of Foreign Issuer (6-k)
06/07/201503:00:00New Xultophy® (IDegLira) Phase 3b Study Showed Statistically...
06/02/201506:10:04Report of Foreign Issuer (6-k)
06/01/201506:32:12Specialized Disclosure Report (sd)
05/27/201508:15:03How Will Big Pharma Fight Back Against MannKind?
05/23/201510:04:02Could Incoming Threats Sink MannKind Corporation?
05/22/201510:58:13Novo Nordisk Hails Success in Diabetes Drug Trial
05/20/201511:07:07Novo Nordisk Signs Autoimmune Disease License Agreement with...
05/20/201510:40:00China Diabetes Management Devices Market Growth to be Driven...
05/20/201510:40:00China Diabetes Management Devices Market Growth to be Driven...
05/20/201507:48:51Report of Foreign Issuer (6-k)
05/17/201510:04:024 Reasons Why MannKind Could Succeed Where Pfizer Failed

Novo Nordisk a S and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations